CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) - April '19 update

from Stock Day Media · host Stock Day Media

CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) returns to the show to talk about licenses granted to them for cannibinoids, working towards precise dosing, and navigating the ever changing regulatory guidelines. clinical studies # CURE Dots # CURE Film # formulating and manufacturing # malaria # medical # oral thin film # pharmaceutical # product testing # sublingual and transdermal applications # veterinarian products Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Apr 15, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) - April '19 update

0:00 7:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 7 minutes long.

When was this Stock Day Media episode published?

This episode was published on April 15, 2019.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!